Dennis Roop
Concepts (838)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epidermis | 84 | 2024 | 155 | 9.050 |
Why?
| Keratins | 113 | 2016 | 175 | 7.090 |
Why?
| Keratinocytes | 56 | 2024 | 242 | 4.430 |
Why?
| Skin Neoplasms | 57 | 2024 | 824 | 4.100 |
Why?
| Membrane Proteins | 39 | 2022 | 1117 | 3.860 |
Why?
| Skin | 53 | 2024 | 726 | 3.410 |
Why?
| Trans-Activators | 26 | 2013 | 388 | 2.980 |
Why?
| Papilloma | 31 | 2011 | 48 | 2.190 |
Why?
| Phosphoproteins | 17 | 2013 | 332 | 2.160 |
Why?
| Cell Transformation, Neoplastic | 25 | 2016 | 327 | 2.150 |
Why?
| Cell Differentiation | 74 | 2024 | 1887 | 2.140 |
Why?
| Hyperkeratosis, Epidermolytic | 17 | 2008 | 21 | 2.070 |
Why?
| Mice, Transgenic | 66 | 2017 | 2117 | 2.000 |
Why?
| NF-E2-Related Factor 2 | 7 | 2022 | 79 | 1.990 |
Why?
| Stem Cells | 19 | 2017 | 574 | 1.950 |
Why?
| Mice | 189 | 2024 | 16915 | 1.880 |
Why?
| Genes, ras | 25 | 2012 | 96 | 1.600 |
Why?
| Animals | 232 | 2024 | 35307 | 1.580 |
Why?
| Hair Follicle | 14 | 2020 | 44 | 1.450 |
Why?
| Genetic Therapy | 12 | 2014 | 288 | 1.320 |
Why?
| Vitiligo | 8 | 2024 | 41 | 1.290 |
Why?
| Mutation | 37 | 2024 | 3710 | 1.180 |
Why?
| Melanocytes | 8 | 2024 | 64 | 1.150 |
Why?
| Point Mutation | 13 | 2009 | 224 | 1.140 |
Why?
| Skin Diseases | 8 | 2014 | 143 | 1.090 |
Why?
| Induced Pluripotent Stem Cells | 6 | 2024 | 221 | 1.080 |
Why?
| Carcinoma, Squamous Cell | 20 | 2016 | 625 | 1.070 |
Why?
| Transforming Growth Factor alpha | 10 | 2000 | 55 | 0.970 |
Why?
| Mice, Knockout | 35 | 2018 | 2871 | 0.960 |
Why?
| Disease Models, Animal | 31 | 2020 | 4057 | 0.960 |
Why?
| Collagen Type VII | 2 | 2024 | 27 | 0.960 |
Why?
| Cell Division | 20 | 2016 | 796 | 0.950 |
Why?
| Ichthyosis | 7 | 2016 | 12 | 0.950 |
Why?
| Epidermolysis Bullosa Dystrophica | 2 | 2024 | 40 | 0.940 |
Why?
| Phenotype | 28 | 2021 | 3074 | 0.890 |
Why?
| Gene Expression Regulation | 31 | 2016 | 2537 | 0.890 |
Why?
| Ectodermal Dysplasia | 5 | 2009 | 16 | 0.880 |
Why?
| Cornified Envelope Proline-Rich Proteins | 7 | 2018 | 9 | 0.870 |
Why?
| Morphogenesis | 7 | 2010 | 158 | 0.860 |
Why?
| Melanoma | 10 | 2020 | 729 | 0.850 |
Why?
| Gene Expression Regulation, Developmental | 14 | 2015 | 820 | 0.850 |
Why?
| Base Sequence | 49 | 2016 | 2146 | 0.850 |
Why?
| Ultraviolet Rays | 9 | 2024 | 382 | 0.840 |
Why?
| DNA-Binding Proteins | 15 | 2015 | 1446 | 0.840 |
Why?
| Genes, fos | 10 | 2000 | 33 | 0.820 |
Why?
| Neoplasms, Experimental | 4 | 2019 | 170 | 0.810 |
Why?
| Transgenes | 13 | 2016 | 177 | 0.800 |
Why?
| Genes, p53 | 10 | 2012 | 70 | 0.800 |
Why?
| Tetradecanoylphorbol Acetate | 21 | 2010 | 149 | 0.790 |
Why?
| Proto-Oncogene Proteins c-myc | 6 | 2010 | 131 | 0.780 |
Why?
| Tumor Suppressor Proteins | 8 | 2009 | 314 | 0.770 |
Why?
| Tumor Suppressor Protein p53 | 6 | 2011 | 509 | 0.760 |
Why?
| Gene Expression Regulation, Neoplastic | 18 | 2015 | 1344 | 0.750 |
Why?
| Skin Pigmentation | 4 | 2024 | 45 | 0.750 |
Why?
| Cells, Cultured | 39 | 2024 | 4076 | 0.750 |
Why?
| Jews | 1 | 2021 | 19 | 0.740 |
Why?
| Intermediate Filament Proteins | 22 | 2012 | 57 | 0.740 |
Why?
| Skin Physiological Phenomena | 7 | 2008 | 24 | 0.730 |
Why?
| Neoplastic Stem Cells | 7 | 2016 | 379 | 0.680 |
Why?
| Cell Lineage | 5 | 2010 | 332 | 0.670 |
Why?
| Ichthyosis, Lamellar | 2 | 2016 | 9 | 0.650 |
Why?
| Cytoskeletal Proteins | 9 | 2012 | 146 | 0.640 |
Why?
| Transcription Factors | 16 | 2015 | 1647 | 0.640 |
Why?
| Intravital Microscopy | 1 | 2019 | 25 | 0.640 |
Why?
| Molecular Sequence Data | 34 | 2012 | 2835 | 0.630 |
Why?
| Genes, myc | 4 | 2011 | 49 | 0.620 |
Why?
| Signal Transduction | 22 | 2020 | 4926 | 0.590 |
Why?
| Hair | 6 | 2012 | 73 | 0.580 |
Why?
| Pluripotent Stem Cells | 2 | 2010 | 77 | 0.580 |
Why?
| Hedgehog Proteins | 7 | 2017 | 187 | 0.570 |
Why?
| Genes | 15 | 2008 | 227 | 0.570 |
Why?
| Immunity, Cellular | 1 | 2019 | 265 | 0.560 |
Why?
| Skin Diseases, Genetic | 6 | 2020 | 11 | 0.560 |
Why?
| Keratin-6 | 5 | 2016 | 6 | 0.540 |
Why?
| Mice, Mutant Strains | 14 | 2016 | 297 | 0.540 |
Why?
| Promoter Regions, Genetic | 17 | 2016 | 1204 | 0.520 |
Why?
| Humans | 132 | 2024 | 129248 | 0.520 |
Why?
| Multipotent Stem Cells | 3 | 2010 | 19 | 0.510 |
Why?
| Amino Acid Sequence | 30 | 2012 | 2056 | 0.510 |
Why?
| Protein Isoforms | 8 | 2008 | 389 | 0.510 |
Why?
| Head and Neck Neoplasms | 5 | 2016 | 542 | 0.500 |
Why?
| Ultraviolet Therapy | 4 | 2024 | 16 | 0.490 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2016 | 133 | 0.490 |
Why?
| Cell Proliferation | 14 | 2024 | 2374 | 0.490 |
Why?
| Keratoderma, Palmoplantar | 3 | 2014 | 5 | 0.490 |
Why?
| Transforming Growth Factor beta | 8 | 2009 | 455 | 0.480 |
Why?
| Viral Proteins | 4 | 2002 | 327 | 0.480 |
Why?
| Pachyonychia Congenita | 3 | 2014 | 4 | 0.470 |
Why?
| Genetic Vectors | 7 | 2013 | 312 | 0.460 |
Why?
| Tretinoin | 11 | 2014 | 130 | 0.460 |
Why?
| Gene Deletion | 8 | 2012 | 380 | 0.450 |
Why?
| Keratosis | 7 | 2000 | 16 | 0.450 |
Why?
| Cell Culture Techniques | 3 | 2014 | 336 | 0.450 |
Why?
| Animals, Newborn | 23 | 2007 | 834 | 0.450 |
Why?
| Epithelium | 14 | 2004 | 311 | 0.450 |
Why?
| Cadherins | 3 | 2016 | 188 | 0.440 |
Why?
| DNA | 24 | 2018 | 1396 | 0.440 |
Why?
| Cell Cycle | 3 | 2012 | 589 | 0.440 |
Why?
| Mice, Inbred ICR | 10 | 2011 | 110 | 0.430 |
Why?
| Genes, Dominant | 6 | 2016 | 92 | 0.430 |
Why?
| Amniotic Fluid | 2 | 2012 | 86 | 0.430 |
Why?
| Mosaicism | 5 | 2014 | 71 | 0.410 |
Why?
| Nails, Malformed | 2 | 2005 | 5 | 0.410 |
Why?
| Up-Regulation | 8 | 2020 | 839 | 0.410 |
Why?
| Proteomics | 2 | 2016 | 1054 | 0.410 |
Why?
| Carcinoma, Basal Cell | 2 | 2017 | 74 | 0.410 |
Why?
| Abnormalities, Multiple | 3 | 2014 | 178 | 0.400 |
Why?
| Wnt Signaling Pathway | 2 | 2024 | 170 | 0.400 |
Why?
| Eyelids | 2 | 2009 | 34 | 0.400 |
Why?
| Keratin-10 | 8 | 2016 | 8 | 0.390 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 17 | 2010 | 24 | 0.390 |
Why?
| Transcription, Genetic | 23 | 2017 | 1416 | 0.390 |
Why?
| Cleft Lip | 2 | 2009 | 43 | 0.390 |
Why?
| Transforming Growth Factor beta2 | 1 | 2012 | 35 | 0.390 |
Why?
| Melanoma, Experimental | 3 | 1998 | 107 | 0.390 |
Why?
| DNA Primers | 13 | 2010 | 510 | 0.390 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2012 | 399 | 0.390 |
Why?
| Carcinogens | 12 | 2010 | 110 | 0.380 |
Why?
| Cleft Palate | 2 | 2009 | 57 | 0.380 |
Why?
| Gene Transfer Techniques | 4 | 2002 | 161 | 0.380 |
Why?
| Mutation, Missense | 3 | 2016 | 317 | 0.380 |
Why?
| Oncogene Proteins v-fos | 6 | 1999 | 11 | 0.380 |
Why?
| Wound Healing | 6 | 2010 | 305 | 0.380 |
Why?
| Apoptosis | 9 | 2012 | 2498 | 0.360 |
Why?
| Calcium | 12 | 2010 | 1212 | 0.360 |
Why?
| Proteins | 3 | 2016 | 941 | 0.360 |
Why?
| Centrosome | 4 | 2012 | 64 | 0.350 |
Why?
| Pedigree | 11 | 2000 | 486 | 0.350 |
Why?
| Hyperplasia | 12 | 2002 | 171 | 0.350 |
Why?
| RNA, Messenger | 35 | 2016 | 2703 | 0.350 |
Why?
| Alleles | 7 | 2016 | 845 | 0.340 |
Why?
| Integrases | 5 | 2004 | 119 | 0.340 |
Why?
| Stem Cell Niche | 1 | 2010 | 53 | 0.330 |
Why?
| Gene Targeting | 5 | 2008 | 82 | 0.330 |
Why?
| Epidermolysis Bullosa Simplex | 4 | 2004 | 10 | 0.320 |
Why?
| Immunotherapy | 3 | 2020 | 592 | 0.320 |
Why?
| Female | 74 | 2024 | 68543 | 0.320 |
Why?
| Transcription Factor AP-2 | 2 | 2008 | 83 | 0.320 |
Why?
| Genes, Recessive | 2 | 2021 | 76 | 0.310 |
Why?
| Mice, Nude | 12 | 2016 | 682 | 0.310 |
Why?
| Polymerase Chain Reaction | 13 | 2002 | 1036 | 0.300 |
Why?
| Mice, Inbred Strains | 13 | 2010 | 406 | 0.290 |
Why?
| Keratins, Type II | 1 | 2007 | 2 | 0.290 |
Why?
| Adenoviridae | 3 | 1998 | 192 | 0.280 |
Why?
| Fluorescent Antibody Technique | 19 | 2004 | 376 | 0.280 |
Why?
| Lipid Metabolism | 5 | 2018 | 497 | 0.280 |
Why?
| Aurora Kinases | 3 | 2012 | 28 | 0.280 |
Why?
| Octamer Transcription Factor-3 | 1 | 2007 | 17 | 0.270 |
Why?
| Disease Progression | 6 | 2019 | 2630 | 0.270 |
Why?
| Aurora Kinase A | 3 | 2012 | 54 | 0.270 |
Why?
| Keratin-14 | 6 | 2012 | 14 | 0.270 |
Why?
| Transcription Factor AP-1 | 3 | 2014 | 88 | 0.270 |
Why?
| Mifepristone | 9 | 2009 | 64 | 0.260 |
Why?
| Mice, Inbred BALB C | 17 | 2020 | 1247 | 0.260 |
Why?
| Amino Acid Substitution | 4 | 2000 | 282 | 0.260 |
Why?
| Skin Transplantation | 6 | 2024 | 84 | 0.260 |
Why?
| Proto-Oncogenes | 1 | 2006 | 29 | 0.260 |
Why?
| Ichthyosiform Erythroderma, Congenital | 2 | 2018 | 6 | 0.260 |
Why?
| Male | 50 | 2024 | 63501 | 0.260 |
Why?
| Models, Biological | 8 | 2016 | 1722 | 0.250 |
Why?
| Homeostasis | 3 | 2020 | 605 | 0.250 |
Why?
| Genes, Reporter | 4 | 2009 | 265 | 0.250 |
Why?
| Genomic Instability | 4 | 2011 | 48 | 0.250 |
Why?
| Cell Line | 14 | 2018 | 2779 | 0.250 |
Why?
| Kelch-Like ECH-Associated Protein 1 | 3 | 2016 | 11 | 0.250 |
Why?
| Lipids | 4 | 2018 | 625 | 0.250 |
Why?
| Mice, Inbred C57BL | 19 | 2015 | 5439 | 0.240 |
Why?
| Oncogene Protein p21(ras) | 4 | 2004 | 16 | 0.240 |
Why?
| Gene Expression | 12 | 2015 | 1466 | 0.240 |
Why?
| Mouth Neoplasms | 2 | 2004 | 84 | 0.240 |
Why?
| Intermediate Filaments | 6 | 2015 | 27 | 0.240 |
Why?
| Keratin-1 | 2 | 2016 | 2 | 0.230 |
Why?
| Skin Diseases, Vesiculobullous | 2 | 1999 | 17 | 0.230 |
Why?
| Phosphodiesterase 4 Inhibitors | 1 | 2024 | 4 | 0.230 |
Why?
| Proto-Oncogene Proteins p21(ras) | 5 | 2015 | 259 | 0.230 |
Why?
| Prenatal Diagnosis | 2 | 1998 | 190 | 0.230 |
Why?
| ras Proteins | 4 | 2013 | 144 | 0.230 |
Why?
| Protein Precursors | 9 | 2006 | 128 | 0.230 |
Why?
| beta Catenin | 3 | 2020 | 223 | 0.230 |
Why?
| Retinoids | 2 | 1997 | 33 | 0.220 |
Why?
| Heterozygote | 4 | 2010 | 272 | 0.220 |
Why?
| Cell- and Tissue-Based Therapy | 1 | 2024 | 76 | 0.220 |
Why?
| Sequence Analysis, DNA | 6 | 2016 | 776 | 0.210 |
Why?
| Cocarcinogenesis | 4 | 2000 | 14 | 0.210 |
Why?
| Lac Operon | 2 | 2000 | 45 | 0.210 |
Why?
| Transduction, Genetic | 4 | 2009 | 128 | 0.210 |
Why?
| Antioxidants | 2 | 2020 | 558 | 0.210 |
Why?
| Transfection | 10 | 2017 | 915 | 0.210 |
Why?
| Proto-Oncogene Proteins | 5 | 2013 | 635 | 0.200 |
Why?
| Tongue | 2 | 2001 | 76 | 0.200 |
Why?
| Oncogenes | 5 | 1994 | 112 | 0.200 |
Why?
| Wnt Proteins | 3 | 2010 | 127 | 0.200 |
Why?
| Cilia | 2 | 2017 | 179 | 0.200 |
Why?
| Cytoskeleton | 8 | 1994 | 183 | 0.200 |
Why?
| Epithelial Cells | 14 | 2006 | 1063 | 0.200 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 947 | 0.200 |
Why?
| Alopecia | 4 | 2005 | 30 | 0.200 |
Why?
| Cell Membrane | 7 | 2015 | 732 | 0.190 |
Why?
| Hindlimb | 2 | 1999 | 122 | 0.190 |
Why?
| Micromanipulation | 1 | 2002 | 14 | 0.190 |
Why?
| Human Growth Hormone | 1 | 2002 | 45 | 0.190 |
Why?
| Chromosome Mapping | 5 | 2016 | 504 | 0.190 |
Why?
| Chile | 1 | 2021 | 20 | 0.190 |
Why?
| Colombia | 1 | 2021 | 36 | 0.190 |
Why?
| Hair Diseases | 1 | 2001 | 9 | 0.190 |
Why?
| Nail Diseases | 1 | 2001 | 6 | 0.190 |
Why?
| Microscopy, Electron | 10 | 2002 | 426 | 0.190 |
Why?
| Permeability | 3 | 2016 | 156 | 0.190 |
Why?
| Blister | 1 | 2001 | 41 | 0.180 |
Why?
| I-kappa B Kinase | 4 | 2009 | 54 | 0.180 |
Why?
| Molecular Imprinting | 1 | 2020 | 4 | 0.180 |
Why?
| Mexico | 1 | 2021 | 190 | 0.180 |
Why?
| Neoplasm Transplantation | 6 | 2016 | 256 | 0.180 |
Why?
| Microscopy, Confocal | 1 | 2002 | 305 | 0.170 |
Why?
| Carcinoma | 5 | 1995 | 215 | 0.170 |
Why?
| RNA | 6 | 2018 | 880 | 0.170 |
Why?
| Ceramides | 3 | 2016 | 112 | 0.170 |
Why?
| Cloning, Molecular | 9 | 2002 | 525 | 0.170 |
Why?
| Regenerative Medicine | 2 | 2019 | 45 | 0.170 |
Why?
| Laser Capture Microdissection | 2 | 2017 | 24 | 0.170 |
Why?
| Adult Stem Cells | 1 | 2020 | 39 | 0.170 |
Why?
| Fibroblasts | 6 | 2024 | 947 | 0.170 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 286 | 0.170 |
Why?
| Blotting, Western | 8 | 2007 | 1204 | 0.170 |
Why?
| Cell Membrane Permeability | 1 | 2020 | 82 | 0.170 |
Why?
| Zebrafish Proteins | 1 | 2002 | 266 | 0.160 |
Why?
| Antineoplastic Agents | 5 | 2016 | 2053 | 0.160 |
Why?
| Molecular Weight | 15 | 1990 | 328 | 0.160 |
Why?
| Papillomaviridae | 3 | 2016 | 114 | 0.160 |
Why?
| Bimatoprost | 1 | 2019 | 3 | 0.160 |
Why?
| Precancerous Conditions | 4 | 2004 | 163 | 0.160 |
Why?
| Immunologic Surveillance | 1 | 2019 | 26 | 0.160 |
Why?
| Genetic Linkage | 4 | 1999 | 299 | 0.160 |
Why?
| Guided Tissue Regeneration | 1 | 2019 | 12 | 0.160 |
Why?
| Crosses, Genetic | 4 | 2010 | 142 | 0.160 |
Why?
| Alopecia Areata | 1 | 2019 | 10 | 0.160 |
Why?
| Skin Aging | 2 | 1997 | 19 | 0.160 |
Why?
| Arginine | 2 | 2007 | 265 | 0.160 |
Why?
| Threonine | 1 | 1999 | 44 | 0.160 |
Why?
| Deafness | 1 | 2000 | 80 | 0.160 |
Why?
| Asparagine | 1 | 1999 | 30 | 0.160 |
Why?
| Thymidine Kinase | 2 | 1998 | 15 | 0.160 |
Why?
| Zinc Finger Protein GLI1 | 2 | 2017 | 23 | 0.160 |
Why?
| Janus Kinase Inhibitors | 1 | 2019 | 25 | 0.160 |
Why?
| Xenograft Model Antitumor Assays | 3 | 2020 | 812 | 0.150 |
Why?
| Ovalbumin | 7 | 1981 | 178 | 0.150 |
Why?
| Caspase 14 | 1 | 2018 | 1 | 0.150 |
Why?
| Tumor Cells, Cultured | 7 | 2016 | 942 | 0.150 |
Why?
| Simplexvirus | 2 | 1998 | 80 | 0.150 |
Why?
| Microscopy, Immunoelectron | 4 | 2016 | 42 | 0.150 |
Why?
| Proto-Oncogene Proteins c-jun | 2 | 1999 | 53 | 0.150 |
Why?
| Cytoprotection | 1 | 2018 | 56 | 0.150 |
Why?
| Cellular Reprogramming Techniques | 1 | 2018 | 11 | 0.150 |
Why?
| Autoimmunity | 1 | 2024 | 862 | 0.140 |
Why?
| Transplantation, Heterologous | 3 | 2011 | 192 | 0.140 |
Why?
| Potoroidae | 2 | 2007 | 3 | 0.140 |
Why?
| Caspase 3 | 2 | 2010 | 245 | 0.140 |
Why?
| Oncogene Proteins, Viral | 2 | 1994 | 22 | 0.140 |
Why?
| Mammary Glands, Animal | 2 | 2006 | 120 | 0.140 |
Why?
| Gene Silencing | 2 | 2016 | 190 | 0.140 |
Why?
| Desmosomes | 2 | 2016 | 21 | 0.140 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2013 | 232 | 0.140 |
Why?
| Receptors, Retinoic Acid | 1 | 1997 | 51 | 0.140 |
Why?
| Protein Multimerization | 1 | 2018 | 178 | 0.140 |
Why?
| Syndrome | 3 | 2009 | 339 | 0.140 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 1997 | 56 | 0.130 |
Why?
| Mutagenesis, Site-Directed | 4 | 1999 | 361 | 0.130 |
Why?
| Neovascularization, Pathologic | 1 | 1998 | 296 | 0.130 |
Why?
| Dermatitis, Atopic | 1 | 2020 | 319 | 0.130 |
Why?
| Glucosylceramides | 1 | 2016 | 6 | 0.130 |
Why?
| Nucleic Acid Hybridization | 13 | 1991 | 189 | 0.130 |
Why?
| Phosphatidylinositol 3-Kinase | 1 | 2016 | 26 | 0.130 |
Why?
| Exons | 2 | 2016 | 341 | 0.130 |
Why?
| Kallikreins | 1 | 2016 | 29 | 0.130 |
Why?
| Recombinant Fusion Proteins | 2 | 1996 | 648 | 0.130 |
Why?
| Bone Morphogenetic Protein 4 | 2 | 2014 | 38 | 0.130 |
Why?
| SOXB1 Transcription Factors | 1 | 2016 | 57 | 0.130 |
Why?
| Side-Population Cells | 2 | 2013 | 8 | 0.130 |
Why?
| Cell Movement | 5 | 2019 | 944 | 0.130 |
Why?
| Gene Amplification | 2 | 2011 | 105 | 0.130 |
Why?
| Aldehyde Dehydrogenase | 2 | 2016 | 101 | 0.130 |
Why?
| Microscopy, Fluorescence | 5 | 2007 | 398 | 0.120 |
Why?
| Epithelial-Mesenchymal Transition | 3 | 2013 | 201 | 0.120 |
Why?
| Amino Acid Motifs | 1 | 2016 | 213 | 0.120 |
Why?
| Genes, Regulator | 2 | 1993 | 34 | 0.120 |
Why?
| Bromodeoxyuridine | 3 | 2001 | 77 | 0.120 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 1999 | 383 | 0.120 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2016 | 138 | 0.120 |
Why?
| Cetuximab | 1 | 2015 | 94 | 0.120 |
Why?
| Hematopoietic Stem Cells | 3 | 2015 | 381 | 0.120 |
Why?
| Receptors, Progesterone | 3 | 2002 | 343 | 0.120 |
Why?
| Hand Deformities, Congenital | 1 | 2014 | 7 | 0.120 |
Why?
| Trachea | 4 | 1993 | 220 | 0.110 |
Why?
| Chloracne | 1 | 2014 | 1 | 0.110 |
Why?
| Cricetinae | 9 | 1994 | 278 | 0.110 |
Why?
| Keratin-2 | 3 | 2000 | 3 | 0.110 |
Why?
| RNA, Neoplasm | 6 | 1995 | 87 | 0.110 |
Why?
| Genes, Tumor Suppressor | 2 | 2004 | 86 | 0.110 |
Why?
| Dermis | 2 | 2010 | 31 | 0.110 |
Why?
| Hearing Loss, Sensorineural | 1 | 2014 | 56 | 0.110 |
Why?
| Cellular Reprogramming | 1 | 2014 | 95 | 0.110 |
Why?
| Transcriptional Activation | 4 | 2007 | 367 | 0.110 |
Why?
| Recombination, Genetic | 2 | 2008 | 190 | 0.110 |
Why?
| Nuclear Proteins | 3 | 2006 | 659 | 0.110 |
Why?
| Hormones | 2 | 1994 | 140 | 0.110 |
Why?
| Embryonic and Fetal Development | 3 | 2002 | 95 | 0.110 |
Why?
| Smad4 Protein | 1 | 2013 | 38 | 0.110 |
Why?
| Genetic Engineering | 2 | 2007 | 86 | 0.110 |
Why?
| Vagina | 3 | 1994 | 174 | 0.110 |
Why?
| DNA Mutational Analysis | 3 | 2018 | 385 | 0.110 |
Why?
| Embryoid Bodies | 1 | 2013 | 7 | 0.100 |
Why?
| Fatty Acid Transport Proteins | 1 | 2012 | 19 | 0.100 |
Why?
| RNA Splice Sites | 1 | 2012 | 44 | 0.100 |
Why?
| DNA Restriction Enzymes | 7 | 1998 | 53 | 0.100 |
Why?
| Keratins, Hair-Specific | 1 | 2012 | 1 | 0.100 |
Why?
| Models, Animal | 4 | 2013 | 376 | 0.100 |
Why?
| Polymorphism, Restriction Fragment Length | 3 | 2004 | 69 | 0.100 |
Why?
| Polyploidy | 1 | 2012 | 18 | 0.100 |
Why?
| Macromolecular Substances | 7 | 1992 | 216 | 0.100 |
Why?
| Fetal Diseases | 1 | 1994 | 158 | 0.100 |
Why?
| Cell Separation | 2 | 2007 | 316 | 0.100 |
Why?
| Carrier Proteins | 2 | 2003 | 742 | 0.100 |
Why?
| RNA, Small Interfering | 3 | 2012 | 591 | 0.100 |
Why?
| Binding Sites | 4 | 2006 | 1249 | 0.100 |
Why?
| Quinone Reductases | 2 | 2002 | 17 | 0.100 |
Why?
| Dermatology | 1 | 2014 | 117 | 0.100 |
Why?
| Immunohistochemistry | 14 | 2007 | 1691 | 0.100 |
Why?
| Embryo, Mammalian | 3 | 2010 | 224 | 0.090 |
Why?
| Cancer Vaccines | 3 | 1998 | 164 | 0.090 |
Why?
| MicroRNAs | 2 | 2015 | 676 | 0.090 |
Why?
| Cerebellar Ataxia | 1 | 2011 | 10 | 0.090 |
Why?
| Immunocompetence | 1 | 2011 | 43 | 0.090 |
Why?
| Regulatory Sequences, Nucleic Acid | 3 | 1999 | 87 | 0.090 |
Why?
| Cell Count | 2 | 1991 | 311 | 0.090 |
Why?
| Epitopes | 3 | 1997 | 470 | 0.090 |
Why?
| Sebaceous Glands | 1 | 2010 | 5 | 0.090 |
Why?
| Keratolytic Agents | 1 | 2010 | 5 | 0.090 |
Why?
| Tumor Microenvironment | 1 | 2015 | 631 | 0.090 |
Why?
| Integrins | 1 | 2011 | 94 | 0.090 |
Why?
| Introns | 4 | 2004 | 251 | 0.090 |
Why?
| Ribosomal Proteins | 1 | 2011 | 77 | 0.090 |
Why?
| Calcification, Physiologic | 1 | 2011 | 33 | 0.090 |
Why?
| Carcinogenesis | 3 | 2021 | 213 | 0.090 |
Why?
| Decidua | 1 | 2010 | 23 | 0.090 |
Why?
| Proto-Oncogene Proteins c-fos | 3 | 1999 | 175 | 0.090 |
Why?
| Nevus | 1 | 2010 | 24 | 0.090 |
Why?
| Biomarkers, Tumor | 7 | 2009 | 1173 | 0.090 |
Why?
| Drug Resistance, Neoplasm | 2 | 2012 | 756 | 0.090 |
Why?
| Neoplasms | 2 | 2006 | 2449 | 0.090 |
Why?
| Polymorphism, Genetic | 1 | 1993 | 639 | 0.090 |
Why?
| Adenocarcinoma, Sebaceous | 1 | 2010 | 1 | 0.090 |
Why?
| Sebaceous Gland Neoplasms | 1 | 2010 | 2 | 0.090 |
Why?
| Genetic Techniques | 2 | 2005 | 63 | 0.090 |
Why?
| Caspase 7 | 1 | 2010 | 22 | 0.080 |
Why?
| Aneuploidy | 2 | 2007 | 92 | 0.080 |
Why?
| In Situ Nick-End Labeling | 2 | 2007 | 124 | 0.080 |
Why?
| Osteoblasts | 1 | 2011 | 116 | 0.080 |
Why?
| Genotype | 4 | 2015 | 1835 | 0.080 |
Why?
| Liver Regeneration | 1 | 2010 | 40 | 0.080 |
Why?
| Organ Specificity | 4 | 2007 | 295 | 0.080 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 2009 | 17 | 0.080 |
Why?
| Neoplasm Recurrence, Local | 1 | 2015 | 958 | 0.080 |
Why?
| Mammary Neoplasms, Experimental | 1 | 1990 | 66 | 0.080 |
Why?
| Teratoma | 1 | 2010 | 103 | 0.080 |
Why?
| Uterus | 1 | 2010 | 207 | 0.080 |
Why?
| Disease Susceptibility | 5 | 2006 | 332 | 0.080 |
Why?
| Mitochondria | 1 | 2015 | 877 | 0.080 |
Why?
| Gene Expression Profiling | 4 | 2015 | 1688 | 0.080 |
Why?
| Selection, Genetic | 1 | 2011 | 249 | 0.080 |
Why?
| Oviducts | 9 | 1982 | 17 | 0.080 |
Why?
| Collagen | 2 | 1988 | 433 | 0.080 |
Why?
| Osteogenesis | 1 | 2011 | 172 | 0.080 |
Why?
| Non-Fibrillar Collagens | 1 | 1988 | 1 | 0.080 |
Why?
| Reactive Oxygen Species | 1 | 2012 | 595 | 0.080 |
Why?
| Down-Regulation | 4 | 2009 | 636 | 0.080 |
Why?
| Pemphigoid, Bullous | 1 | 1988 | 8 | 0.080 |
Why?
| Muscle, Smooth | 1 | 1990 | 157 | 0.080 |
Why?
| Receptor, Notch1 | 2 | 2006 | 61 | 0.080 |
Why?
| Stress, Physiological | 1 | 2012 | 414 | 0.080 |
Why?
| Gene Knockdown Techniques | 1 | 2009 | 316 | 0.080 |
Why?
| Spindle Apparatus | 1 | 2009 | 94 | 0.080 |
Why?
| beta-Galactosidase | 2 | 1999 | 77 | 0.080 |
Why?
| Foot | 1 | 2009 | 93 | 0.070 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2005 | 117 | 0.070 |
Why?
| Integrin beta1 | 2 | 2013 | 22 | 0.070 |
Why?
| Genes, Lethal | 2 | 2008 | 29 | 0.070 |
Why?
| Hand | 1 | 2009 | 155 | 0.070 |
Why?
| Cytoplasmic Granules | 4 | 2002 | 78 | 0.070 |
Why?
| Cell Death | 1 | 2009 | 354 | 0.070 |
Why?
| Adult | 10 | 2020 | 35495 | 0.070 |
Why?
| Bone Marrow | 2 | 2015 | 271 | 0.070 |
Why?
| Hoof and Claw | 1 | 2007 | 5 | 0.070 |
Why?
| Olfactory Mucosa | 1 | 2008 | 64 | 0.070 |
Why?
| Protein Conformation | 6 | 1992 | 861 | 0.070 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 442 | 0.070 |
Why?
| Protein Structure, Tertiary | 2 | 2007 | 841 | 0.070 |
Why?
| Langerhans Cells | 2 | 1997 | 11 | 0.070 |
Why?
| Cell Line, Tumor | 5 | 2015 | 3201 | 0.070 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1998 | 147 | 0.070 |
Why?
| Growth Substances | 2 | 1999 | 150 | 0.070 |
Why?
| Caspase 9 | 1 | 2007 | 56 | 0.070 |
Why?
| Species Specificity | 3 | 2000 | 574 | 0.070 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1555 | 0.070 |
Why?
| Neoplasm Proteins | 2 | 2006 | 422 | 0.070 |
Why?
| Chloramphenicol O-Acetyltransferase | 2 | 1999 | 38 | 0.070 |
Why?
| Coculture Techniques | 2 | 2024 | 223 | 0.070 |
Why?
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 16 | 0.070 |
Why?
| Cell Adhesion | 3 | 2015 | 452 | 0.070 |
Why?
| Interleukin-1alpha | 2 | 2020 | 56 | 0.070 |
Why?
| Ganciclovir | 2 | 1998 | 52 | 0.070 |
Why?
| Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 66 | 0.070 |
Why?
| Glycine | 1 | 2007 | 165 | 0.060 |
Why?
| Biological Assay | 1 | 2007 | 118 | 0.060 |
Why?
| Twist-Related Protein 1 | 1 | 2006 | 8 | 0.060 |
Why?
| Lymphatic Metastasis | 1 | 2007 | 320 | 0.060 |
Why?
| Mice, SCID | 3 | 2013 | 350 | 0.060 |
Why?
| Blotting, Northern | 6 | 1992 | 201 | 0.060 |
Why?
| Phorbols | 1 | 1985 | 10 | 0.060 |
Why?
| Darier Disease | 1 | 2005 | 2 | 0.060 |
Why?
| Antibodies | 2 | 1985 | 398 | 0.060 |
Why?
| Autoantigens | 1 | 1988 | 419 | 0.060 |
Why?
| Stomach | 2 | 2006 | 109 | 0.060 |
Why?
| Protein Structure, Secondary | 2 | 1999 | 340 | 0.060 |
Why?
| Models, Genetic | 3 | 2008 | 593 | 0.060 |
Why?
| Nucleic Acid Precursors | 3 | 1980 | 24 | 0.060 |
Why?
| Enzyme Activation | 1 | 2007 | 812 | 0.060 |
Why?
| Flow Cytometry | 2 | 2007 | 1155 | 0.060 |
Why?
| Recombinant Proteins | 2 | 1999 | 1304 | 0.060 |
Why?
| Oxidative Stress | 1 | 2012 | 1265 | 0.060 |
Why?
| Cell Cycle Proteins | 2 | 2006 | 584 | 0.060 |
Why?
| Cyclins | 2 | 1996 | 89 | 0.060 |
Why?
| Cell Adhesion Molecules | 1 | 2006 | 173 | 0.060 |
Why?
| Skin Abnormalities | 2 | 2002 | 12 | 0.060 |
Why?
| Retinal Dehydrogenase | 2 | 2016 | 30 | 0.060 |
Why?
| Embryonic Development | 1 | 2005 | 114 | 0.060 |
Why?
| Nerve Tissue Proteins | 1 | 1988 | 569 | 0.060 |
Why?
| RNA Interference | 3 | 2013 | 450 | 0.060 |
Why?
| Sequence Analysis, RNA | 2 | 2017 | 428 | 0.060 |
Why?
| Melanins | 1 | 2024 | 18 | 0.060 |
Why?
| Calcineurin | 1 | 2005 | 98 | 0.060 |
Why?
| Cyclopropanes | 1 | 2024 | 89 | 0.060 |
Why?
| Electrophoresis, Polyacrylamide Gel | 4 | 1990 | 327 | 0.060 |
Why?
| Homeodomain Proteins | 2 | 2006 | 495 | 0.060 |
Why?
| Boron Compounds | 1 | 2024 | 22 | 0.060 |
Why?
| United States | 1 | 2021 | 13828 | 0.060 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2024 | 9 | 0.060 |
Why?
| Transglutaminases | 3 | 1995 | 153 | 0.060 |
Why?
| Blotting, Southern | 3 | 2001 | 69 | 0.060 |
Why?
| Pregnancy | 5 | 2010 | 6391 | 0.050 |
Why?
| Aminopyridines | 1 | 2024 | 97 | 0.050 |
Why?
| In Vitro Techniques | 4 | 2013 | 1085 | 0.050 |
Why?
| Gene Editing | 1 | 2024 | 67 | 0.050 |
Why?
| Benzamides | 1 | 2024 | 207 | 0.050 |
Why?
| Receptors, Cell Surface | 2 | 2005 | 380 | 0.050 |
Why?
| Transplantation, Autologous | 1 | 2024 | 211 | 0.050 |
Why?
| Time Factors | 5 | 2004 | 6543 | 0.050 |
Why?
| Body Weight | 2 | 2011 | 939 | 0.050 |
Why?
| Tissue Distribution | 2 | 2002 | 315 | 0.050 |
Why?
| CRISPR-Cas Systems | 1 | 2024 | 108 | 0.050 |
Why?
| Vimentin | 4 | 1994 | 50 | 0.050 |
Why?
| Molecular Structure | 2 | 1994 | 478 | 0.050 |
Why?
| Biomarkers | 5 | 2004 | 3966 | 0.050 |
Why?
| Vitamin K 3 | 1 | 2002 | 3 | 0.050 |
Why?
| Genetic Variation | 2 | 1998 | 938 | 0.050 |
Why?
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 215 | 0.050 |
Why?
| S100 Proteins | 2 | 2000 | 36 | 0.050 |
Why?
| Dacarbazine | 2 | 2012 | 93 | 0.050 |
Why?
| Keratin-15 | 1 | 2002 | 14 | 0.050 |
Why?
| Bioreactors | 1 | 2002 | 42 | 0.050 |
Why?
| Keratin-5 | 1 | 2002 | 50 | 0.050 |
Why?
| Mesocricetus | 5 | 1993 | 37 | 0.050 |
Why?
| Isomerism | 1 | 2001 | 53 | 0.050 |
Why?
| Immunoenzyme Techniques | 4 | 1993 | 214 | 0.050 |
Why?
| 3T3 Cells | 3 | 2013 | 153 | 0.050 |
Why?
| Starvation | 1 | 2001 | 22 | 0.050 |
Why?
| Vitamin A Deficiency | 3 | 1993 | 26 | 0.050 |
Why?
| Luteolytic Agents | 1 | 2001 | 1 | 0.050 |
Why?
| Mouth Diseases | 1 | 2001 | 43 | 0.050 |
Why?
| Bone and Bones | 1 | 2004 | 295 | 0.050 |
Why?
| Administration, Topical | 3 | 1997 | 145 | 0.040 |
Why?
| Lasers | 1 | 2002 | 132 | 0.040 |
Why?
| Benzo(a)pyrene | 1 | 2000 | 7 | 0.040 |
Why?
| Protein-Tyrosine Kinases | 1 | 2004 | 432 | 0.040 |
Why?
| Response Elements | 2 | 2012 | 90 | 0.040 |
Why?
| Nuclear Localization Signals | 1 | 2000 | 15 | 0.040 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2000 | 32 | 0.040 |
Why?
| Autoantibodies | 1 | 1988 | 1467 | 0.040 |
Why?
| Frameshift Mutation | 1 | 2000 | 32 | 0.040 |
Why?
| Cell Compartmentation | 1 | 2000 | 52 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 1 | 2001 | 372 | 0.040 |
Why?
| Netherton Syndrome | 1 | 2020 | 3 | 0.040 |
Why?
| Dermatitis, Exfoliative | 1 | 2020 | 4 | 0.040 |
Why?
| Cell Survival | 3 | 2013 | 1074 | 0.040 |
Why?
| Rats | 5 | 1994 | 5482 | 0.040 |
Why?
| Adaptation, Biological | 1 | 2000 | 54 | 0.040 |
Why?
| Zebrafish | 1 | 2004 | 458 | 0.040 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2020 | 50 | 0.040 |
Why?
| Chickens | 9 | 1995 | 189 | 0.040 |
Why?
| Immunoblotting | 4 | 2003 | 305 | 0.040 |
Why?
| Cell Nucleus | 7 | 2004 | 586 | 0.040 |
Why?
| Repressor Proteins | 2 | 2013 | 406 | 0.040 |
Why?
| rho GTP-Binding Proteins | 1 | 2020 | 61 | 0.040 |
Why?
| Kidney | 1 | 2007 | 1385 | 0.040 |
Why?
| Estrenes | 1 | 1999 | 16 | 0.040 |
Why?
| DNA, Complementary | 2 | 2003 | 271 | 0.040 |
Why?
| DNA, Neoplasm | 3 | 1995 | 158 | 0.040 |
Why?
| Genomic Library | 1 | 1999 | 15 | 0.040 |
Why?
| Restriction Mapping | 1 | 1999 | 75 | 0.040 |
Why?
| Phototherapy | 1 | 2019 | 30 | 0.040 |
Why?
| Genetic Carrier Screening | 1 | 1999 | 26 | 0.040 |
Why?
| DNA Damage | 2 | 2012 | 383 | 0.040 |
Why?
| Forelimb | 1 | 1999 | 28 | 0.040 |
Why?
| Cell Self Renewal | 1 | 2019 | 53 | 0.040 |
Why?
| Protein Transport | 1 | 2000 | 428 | 0.040 |
Why?
| RNA, Heterogeneous Nuclear | 1 | 1978 | 4 | 0.040 |
Why?
| Sequence Analysis | 1 | 1998 | 37 | 0.040 |
Why?
| Breast Neoplasms | 1 | 2011 | 2140 | 0.040 |
Why?
| Reference Values | 3 | 2002 | 793 | 0.040 |
Why?
| Thrombospondin 1 | 1 | 1998 | 26 | 0.040 |
Why?
| Peptides | 1 | 1984 | 923 | 0.040 |
Why?
| Dimerization | 1 | 1999 | 191 | 0.040 |
Why?
| Fungal Proteins | 1 | 1999 | 130 | 0.040 |
Why?
| Vascular Endothelial Growth Factors | 1 | 1998 | 78 | 0.040 |
Why?
| Endothelial Growth Factors | 1 | 1998 | 63 | 0.040 |
Why?
| Lymphokines | 1 | 1998 | 127 | 0.040 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 756 | 0.040 |
Why?
| Feasibility Studies | 1 | 2002 | 867 | 0.040 |
Why?
| Body Patterning | 1 | 1999 | 128 | 0.040 |
Why?
| Mutagenesis, Insertional | 1 | 1998 | 65 | 0.040 |
Why?
| Genes, bcl-2 | 1 | 1998 | 21 | 0.040 |
Why?
| Neovascularization, Physiologic | 1 | 1999 | 175 | 0.040 |
Why?
| Psoriasis | 2 | 1996 | 87 | 0.040 |
Why?
| Age of Onset | 1 | 1999 | 496 | 0.040 |
Why?
| Gamma Rays | 1 | 1998 | 54 | 0.040 |
Why?
| Genetic Predisposition to Disease | 1 | 2006 | 2276 | 0.030 |
Why?
| Protein Binding | 3 | 2009 | 2120 | 0.030 |
Why?
| Antigens, Neoplasm | 2 | 1997 | 308 | 0.030 |
Why?
| Retinoic Acid Receptor alpha | 1 | 1997 | 15 | 0.030 |
Why?
| Thymus Gland | 1 | 1998 | 308 | 0.030 |
Why?
| Biomechanical Phenomena | 1 | 2000 | 757 | 0.030 |
Why?
| Oxazines | 1 | 1997 | 27 | 0.030 |
Why?
| Epidermal Growth Factor | 3 | 1993 | 170 | 0.030 |
Why?
| Retinoid X Receptors | 1 | 1997 | 41 | 0.030 |
Why?
| Mitotic Index | 1 | 1997 | 26 | 0.030 |
Why?
| Metaplasia | 3 | 1993 | 54 | 0.030 |
Why?
| Receptors, Calcitriol | 1 | 1997 | 54 | 0.030 |
Why?
| Clinical Trials, Phase II as Topic | 1 | 1997 | 72 | 0.030 |
Why?
| Clinical Trials, Phase I as Topic | 1 | 1997 | 50 | 0.030 |
Why?
| Luciferases | 2 | 2009 | 147 | 0.030 |
Why?
| Carcinogenicity Tests | 2 | 1994 | 6 | 0.030 |
Why?
| Hybrid Cells | 2 | 1994 | 50 | 0.030 |
Why?
| Hypertrophy | 1 | 1997 | 121 | 0.030 |
Why?
| Interleukin-2 | 1 | 1998 | 437 | 0.030 |
Why?
| Body Temperature | 1 | 1997 | 212 | 0.030 |
Why?
| Organ Culture Techniques | 4 | 1990 | 153 | 0.030 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1987 | 111 | 0.030 |
Why?
| Hyaluronan Receptors | 1 | 2016 | 96 | 0.030 |
Why?
| Extremities | 1 | 1997 | 127 | 0.030 |
Why?
| Rats, Inbred F344 | 2 | 1993 | 259 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 1998 | 530 | 0.030 |
Why?
| Spheroids, Cellular | 1 | 2016 | 77 | 0.030 |
Why?
| Kinetics | 5 | 1994 | 1644 | 0.030 |
Why?
| Neoplasm Metastasis | 1 | 1998 | 610 | 0.030 |
Why?
| Rabbits | 2 | 1996 | 777 | 0.030 |
Why?
| Phospholipids | 1 | 1997 | 215 | 0.030 |
Why?
| Fluorescent Dyes | 1 | 1997 | 312 | 0.030 |
Why?
| Maximum Tolerated Dose | 1 | 2015 | 193 | 0.030 |
Why?
| Biopsy | 2 | 1997 | 1091 | 0.030 |
Why?
| PAX3 Transcription Factor | 1 | 2015 | 11 | 0.030 |
Why?
| Paired Box Transcription Factors | 1 | 2015 | 40 | 0.030 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1995 | 151 | 0.030 |
Why?
| Inhibins | 1 | 1995 | 45 | 0.030 |
Why?
| Interleukins | 1 | 1997 | 241 | 0.030 |
Why?
| Random Allocation | 1 | 2016 | 346 | 0.030 |
Why?
| Intramolecular Oxidoreductases | 1 | 2015 | 67 | 0.030 |
Why?
| Benzoates | 1 | 1995 | 41 | 0.030 |
Why?
| Cantharidin | 1 | 1994 | 1 | 0.030 |
Why?
| Ainhum | 1 | 2014 | 1 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 328 | 0.030 |
Why?
| Tetrahydronaphthalenes | 1 | 1995 | 30 | 0.030 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 1997 | 207 | 0.030 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2015 | 68 | 0.030 |
Why?
| Combined Modality Therapy | 1 | 1998 | 1199 | 0.030 |
Why?
| DNA Probes, HPV | 1 | 1994 | 1 | 0.030 |
Why?
| Evaluation Studies as Topic | 1 | 1994 | 173 | 0.030 |
Why?
| Middle Aged | 5 | 2020 | 31087 | 0.030 |
Why?
| Staining and Labeling | 2 | 2010 | 141 | 0.030 |
Why?
| Sequence Alignment | 1 | 1995 | 332 | 0.030 |
Why?
| Lung Neoplasms | 1 | 2007 | 2342 | 0.030 |
Why?
| Immunity, Innate | 1 | 2020 | 803 | 0.030 |
Why?
| Actin Cytoskeleton | 1 | 1995 | 104 | 0.030 |
Why?
| Ornithine Decarboxylase | 1 | 1994 | 10 | 0.030 |
Why?
| Epigen | 1 | 2014 | 1 | 0.030 |
Why?
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2014 | 6 | 0.030 |
Why?
| Open Reading Frames | 1 | 1994 | 116 | 0.030 |
Why?
| Disease-Free Survival | 1 | 2015 | 645 | 0.030 |
Why?
| Collagen Type IV | 1 | 2014 | 23 | 0.030 |
Why?
| Chorionic Villi | 1 | 1994 | 22 | 0.030 |
Why?
| Simian virus 40 | 1 | 1993 | 24 | 0.030 |
Why?
| TATA Box | 1 | 1993 | 24 | 0.030 |
Why?
| Treatment Outcome | 2 | 2020 | 10199 | 0.030 |
Why?
| Antigens, CD | 1 | 2016 | 489 | 0.030 |
Why?
| Laminin | 1 | 1994 | 69 | 0.030 |
Why?
| alpha Catenin | 1 | 2013 | 12 | 0.030 |
Why?
| Butylhydroxybutylnitrosamine | 1 | 1993 | 6 | 0.030 |
Why?
| Cholecalciferol | 1 | 1994 | 56 | 0.030 |
Why?
| Infant, Newborn | 2 | 2009 | 5736 | 0.030 |
Why?
| Clone Cells | 2 | 2010 | 262 | 0.030 |
Why?
| Constriction, Pathologic | 1 | 2014 | 226 | 0.030 |
Why?
| Protein Biosynthesis | 6 | 1991 | 405 | 0.030 |
Why?
| Cell Dedifferentiation | 1 | 2013 | 30 | 0.030 |
Why?
| Multigene Family | 1 | 1994 | 199 | 0.030 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 45 | 0.030 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2016 | 396 | 0.030 |
Why?
| Ovariectomy | 1 | 1994 | 135 | 0.030 |
Why?
| Viruses | 1 | 1994 | 100 | 0.030 |
Why?
| Mice, Inbred CBA | 1 | 2013 | 52 | 0.030 |
Why?
| Collagen Type I | 1 | 2014 | 118 | 0.030 |
Why?
| Sulfur Radioisotopes | 2 | 1990 | 15 | 0.030 |
Why?
| DNA Probes | 2 | 1992 | 61 | 0.030 |
Why?
| ErbB Receptors | 1 | 2016 | 605 | 0.030 |
Why?
| Child | 3 | 2020 | 20773 | 0.030 |
Why?
| Sequence Deletion | 1 | 2013 | 179 | 0.030 |
Why?
| Glycoproteins | 1 | 1995 | 338 | 0.030 |
Why?
| Chromosomes, Mammalian | 1 | 2012 | 25 | 0.030 |
Why?
| Lentivirus | 1 | 2013 | 53 | 0.030 |
Why?
| Forecasting | 1 | 1994 | 359 | 0.030 |
Why?
| Aldehyde Oxidoreductases | 1 | 2012 | 27 | 0.030 |
Why?
| Breast | 1 | 1993 | 153 | 0.030 |
Why?
| Diseases in Twins | 1 | 1994 | 175 | 0.020 |
Why?
| Egg Proteins | 3 | 1982 | 17 | 0.020 |
Why?
| Serine | 1 | 1993 | 138 | 0.020 |
Why?
| Bacteriophage lambda | 1 | 1993 | 88 | 0.020 |
Why?
| Coloring Agents | 1 | 2012 | 77 | 0.020 |
Why?
| Limb Buds | 2 | 2004 | 22 | 0.020 |
Why?
| Cysteine | 1 | 1993 | 195 | 0.020 |
Why?
| Isoenzymes | 1 | 2012 | 302 | 0.020 |
Why?
| Tritium | 3 | 1994 | 75 | 0.020 |
Why?
| Myoepithelioma | 1 | 1991 | 3 | 0.020 |
Why?
| Mutagenicity Tests | 1 | 2011 | 8 | 0.020 |
Why?
| Gene Knock-In Techniques | 1 | 2011 | 53 | 0.020 |
Why?
| Biological Evolution | 2 | 1985 | 432 | 0.020 |
Why?
| Age Factors | 2 | 1996 | 3140 | 0.020 |
Why?
| Avian Leukosis Virus | 1 | 2011 | 6 | 0.020 |
Why?
| Proteome | 1 | 2015 | 438 | 0.020 |
Why?
| Integrin-Binding Sialoprotein | 1 | 2011 | 5 | 0.020 |
Why?
| Ovomucin | 2 | 1982 | 4 | 0.020 |
Why?
| Infant | 2 | 2009 | 8975 | 0.020 |
Why?
| Haploinsufficiency | 1 | 2011 | 48 | 0.020 |
Why?
| Rodent Diseases | 1 | 1991 | 28 | 0.020 |
Why?
| Moloney murine leukemia virus | 1 | 1991 | 13 | 0.020 |
Why?
| Hyperpigmentation | 1 | 2011 | 25 | 0.020 |
Why?
| Interleukin-8 | 1 | 2012 | 262 | 0.020 |
Why?
| Progesterone | 2 | 2010 | 245 | 0.020 |
Why?
| Osteocalcin | 1 | 2011 | 36 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1837 | 0.020 |
Why?
| Paclitaxel | 1 | 2012 | 217 | 0.020 |
Why?
| Growth Disorders | 1 | 2011 | 80 | 0.020 |
Why?
| Immunosorbent Techniques | 2 | 1987 | 19 | 0.020 |
Why?
| Wnt4 Protein | 1 | 2010 | 18 | 0.020 |
Why?
| Embryo Implantation | 1 | 2010 | 28 | 0.020 |
Why?
| Mice, Inbred NOD | 1 | 2012 | 588 | 0.020 |
Why?
| Swine | 1 | 1993 | 760 | 0.020 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1997 | 857 | 0.020 |
Why?
| Pilot Projects | 1 | 2015 | 1584 | 0.020 |
Why?
| Cytokines | 2 | 2015 | 2013 | 0.020 |
Why?
| DNA Repair | 1 | 2012 | 206 | 0.020 |
Why?
| Estrogens | 4 | 1982 | 346 | 0.020 |
Why?
| Mitosis | 1 | 2011 | 180 | 0.020 |
Why?
| Child, Preschool | 2 | 2009 | 10456 | 0.020 |
Why?
| Pigmentation | 1 | 2010 | 52 | 0.020 |
Why?
| Urinary Bladder Neoplasms | 1 | 1993 | 226 | 0.020 |
Why?
| Transcriptome | 1 | 2016 | 874 | 0.020 |
Why?
| Phospholipases A2 | 1 | 2010 | 79 | 0.020 |
Why?
| T-Lymphocytes | 1 | 1998 | 1933 | 0.020 |
Why?
| Animals, Wild | 1 | 1990 | 54 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 1994 | 1430 | 0.020 |
Why?
| Adenoma, Pleomorphic | 1 | 1990 | 9 | 0.020 |
Why?
| Liver | 2 | 2002 | 1839 | 0.020 |
Why?
| Parotid Neoplasms | 1 | 1990 | 16 | 0.020 |
Why?
| Mouth Mucosa | 1 | 1990 | 88 | 0.020 |
Why?
| Smad3 Protein | 1 | 2009 | 43 | 0.020 |
Why?
| Follow-Up Studies | 1 | 1999 | 4886 | 0.020 |
Why?
| Enzyme Induction | 1 | 2009 | 90 | 0.020 |
Why?
| Anemia | 1 | 2011 | 160 | 0.020 |
Why?
| Amino Acids | 4 | 2002 | 486 | 0.020 |
Why?
| Arachidonic Acid | 1 | 2010 | 115 | 0.020 |
Why?
| Mice, Inbred C3H | 1 | 1990 | 272 | 0.020 |
Why?
| Imidazoles | 1 | 2010 | 234 | 0.020 |
Why?
| Chromatin Immunoprecipitation | 1 | 2009 | 132 | 0.020 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2009 | 84 | 0.020 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2010 | 154 | 0.020 |
Why?
| Dinoprostone | 1 | 2010 | 187 | 0.020 |
Why?
| Diethylstilbestrol | 2 | 1979 | 9 | 0.020 |
Why?
| Dystonin | 1 | 1988 | 1 | 0.020 |
Why?
| Cellular Senescence | 1 | 2010 | 181 | 0.020 |
Why?
| Ameloblastoma | 1 | 1988 | 5 | 0.020 |
Why?
| Case-Control Studies | 1 | 2016 | 3377 | 0.020 |
Why?
| Methionine | 1 | 1989 | 156 | 0.020 |
Why?
| Lactation | 1 | 1990 | 169 | 0.020 |
Why?
| Cell Communication | 1 | 2010 | 300 | 0.020 |
Why?
| Tissue Scaffolds | 1 | 2011 | 201 | 0.020 |
Why?
| gamma-Glutamyltransferase | 1 | 1988 | 42 | 0.020 |
Why?
| Vitamin A | 2 | 1986 | 55 | 0.020 |
Why?
| Piperazines | 1 | 2010 | 341 | 0.020 |
Why?
| Neoplasm Invasiveness | 1 | 2009 | 483 | 0.020 |
Why?
| Isoelectric Point | 1 | 1987 | 23 | 0.020 |
Why?
| Antigens, Differentiation | 1 | 1988 | 81 | 0.020 |
Why?
| Organoids | 1 | 1988 | 104 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 833 | 0.020 |
Why?
| Survival Analysis | 1 | 2010 | 1269 | 0.020 |
Why?
| Interferon-gamma | 1 | 1990 | 772 | 0.020 |
Why?
| Protease Inhibitors | 1 | 1988 | 106 | 0.020 |
Why?
| Antigens, Ly | 1 | 1987 | 44 | 0.020 |
Why?
| Harvey murine sarcoma virus | 1 | 1986 | 1 | 0.020 |
Why?
| Dimethyl Sulfoxide | 1 | 1987 | 41 | 0.020 |
Why?
| Occludin | 1 | 2006 | 11 | 0.020 |
Why?
| LIM Domain Proteins | 1 | 2006 | 17 | 0.020 |
Why?
| Interleukin-6 | 1 | 1990 | 720 | 0.020 |
Why?
| Claudin-1 | 1 | 2006 | 21 | 0.020 |
Why?
| Minichromosome Maintenance Complex Component 7 | 1 | 2006 | 4 | 0.020 |
Why?
| Immunoassay | 1 | 1987 | 107 | 0.020 |
Why?
| Receptors, Steroid | 1 | 2006 | 50 | 0.020 |
Why?
| Olfactory Bulb | 1 | 2008 | 136 | 0.020 |
Why?
| Chemistry | 1 | 1985 | 45 | 0.020 |
Why?
| Chemical Phenomena | 1 | 1985 | 82 | 0.020 |
Why?
| Fluocinolone Acetonide | 1 | 1985 | 19 | 0.020 |
Why?
| X-Ray Diffraction | 1 | 1985 | 94 | 0.020 |
Why?
| Calcium-Binding Proteins | 1 | 1986 | 211 | 0.010 |
Why?
| Phosphorylation | 1 | 2009 | 1710 | 0.010 |
Why?
| HeLa Cells | 1 | 2007 | 611 | 0.010 |
Why?
| Microscopy, Electron, Scanning | 1 | 1985 | 196 | 0.010 |
Why?
| Erythroid-Specific DNA-Binding Factors | 1 | 2004 | 18 | 0.010 |
Why?
| Aged | 3 | 2020 | 22032 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2012 | 2063 | 0.010 |
Why?
| Cattle | 2 | 1988 | 977 | 0.010 |
Why?
| Calcineurin Inhibitors | 1 | 2005 | 68 | 0.010 |
Why?
| YY1 Transcription Factor | 1 | 2004 | 28 | 0.010 |
Why?
| NFATC Transcription Factors | 1 | 2005 | 84 | 0.010 |
Why?
| Protein Processing, Post-Translational | 1 | 1987 | 454 | 0.010 |
Why?
| Base Composition | 1 | 1984 | 76 | 0.010 |
Why?
| Hormone Antagonists | 1 | 2004 | 32 | 0.010 |
Why?
| Thymidine | 2 | 1994 | 59 | 0.010 |
Why?
| Antigen-Antibody Complex | 1 | 1984 | 85 | 0.010 |
Why?
| Fibroblast Growth Factor 8 | 1 | 2004 | 27 | 0.010 |
Why?
| Young Adult | 1 | 2020 | 12388 | 0.010 |
Why?
| Terminology as Topic | 1 | 1985 | 203 | 0.010 |
Why?
| Antibodies, Monoclonal | 2 | 1990 | 1367 | 0.010 |
Why?
| Interleukin-1 | 1 | 1988 | 959 | 0.010 |
Why?
| Receptors, Fibroblast Growth Factor | 1 | 2004 | 65 | 0.010 |
Why?
| src-Family Kinases | 1 | 2004 | 95 | 0.010 |
Why?
| Craniofacial Abnormalities | 1 | 2004 | 63 | 0.010 |
Why?
| Stomach Diseases | 1 | 2003 | 20 | 0.010 |
Why?
| Weaning | 1 | 2003 | 48 | 0.010 |
Why?
| Adolescent | 2 | 2020 | 20303 | 0.010 |
Why?
| Esophageal Diseases | 1 | 2003 | 27 | 0.010 |
Why?
| Extracellular Matrix | 1 | 1987 | 502 | 0.010 |
Why?
| Clinical Trials as Topic | 1 | 2008 | 1004 | 0.010 |
Why?
| Mice, Hairless | 2 | 1994 | 60 | 0.010 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2003 | 67 | 0.010 |
Why?
| Fibroblast Growth Factors | 1 | 2004 | 169 | 0.010 |
Why?
| Aging | 1 | 1993 | 1774 | 0.010 |
Why?
| Cheek | 2 | 1993 | 15 | 0.010 |
Why?
| Fertility | 1 | 2002 | 155 | 0.010 |
Why?
| RNA, Small Nuclear | 1 | 1981 | 35 | 0.010 |
Why?
| Mice, Inbred A | 1 | 2000 | 48 | 0.010 |
Why?
| Biotransformation | 1 | 2000 | 66 | 0.010 |
Why?
| Peptide Fragments | 1 | 1984 | 692 | 0.010 |
Why?
| Risk Factors | 1 | 1994 | 9745 | 0.010 |
Why?
| Limb Deformities, Congenital | 1 | 1999 | 12 | 0.010 |
Why?
| Sequence Homology | 1 | 1999 | 40 | 0.010 |
Why?
| Neurons | 1 | 2008 | 1494 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2003 | 2008 | 0.010 |
Why?
| Phosphorus Radioisotopes | 1 | 1978 | 29 | 0.010 |
Why?
| Globins | 1 | 1978 | 21 | 0.010 |
Why?
| Reticulocytes | 1 | 1978 | 18 | 0.010 |
Why?
| Cholera Toxin | 2 | 1988 | 31 | 0.010 |
Why?
| Polyribosomes | 1 | 1978 | 21 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 100 | 0.010 |
Why?
| Antibody Specificity | 2 | 1989 | 184 | 0.010 |
Why?
| DNA Fragmentation | 1 | 1998 | 44 | 0.010 |
Why?
| Drug Stability | 1 | 1978 | 159 | 0.010 |
Why?
| RNA Polymerase II | 1 | 1981 | 317 | 0.010 |
Why?
| Isotope Labeling | 1 | 1978 | 74 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 336 | 0.010 |
Why?
| Immunologic Techniques | 2 | 1986 | 39 | 0.010 |
Why?
| Desmogleins | 1 | 1996 | 3 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 412 | 0.010 |
Why?
| Desmoplakins | 1 | 1996 | 19 | 0.010 |
Why?
| Receptors, Estrogen | 1 | 1979 | 426 | 0.010 |
Why?
| Follistatin | 1 | 1995 | 12 | 0.010 |
Why?
| Activins | 1 | 1995 | 27 | 0.010 |
Why?
| Musculoskeletal Abnormalities | 1 | 1995 | 11 | 0.010 |
Why?
| Vibrissae | 1 | 1995 | 10 | 0.010 |
Why?
| Xenopus | 1 | 1995 | 86 | 0.010 |
Why?
| Palate | 1 | 1995 | 35 | 0.010 |
Why?
| Musculoskeletal System | 1 | 1995 | 46 | 0.010 |
Why?
| Estrus | 1 | 1994 | 12 | 0.010 |
Why?
| Acetone | 1 | 1994 | 12 | 0.010 |
Why?
| Membrane Glycoproteins | 1 | 1997 | 476 | 0.010 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1998 | 704 | 0.010 |
Why?
| Lymph Nodes | 1 | 1997 | 470 | 0.010 |
Why?
| Skull | 1 | 1995 | 129 | 0.010 |
Why?
| Dendritic Cells | 1 | 1997 | 479 | 0.010 |
Why?
| Cell Fusion | 1 | 1993 | 51 | 0.010 |
Why?
| Protein Kinase C | 1 | 1994 | 260 | 0.010 |
Why?
| Organelles | 1 | 1991 | 54 | 0.010 |
Why?
| Cell Line, Transformed | 1 | 1991 | 140 | 0.010 |
Why?
| Retroviridae | 1 | 1991 | 99 | 0.010 |
Why?
| Peptide Mapping | 1 | 1990 | 63 | 0.010 |
Why?
| Trypsin | 1 | 1990 | 74 | 0.010 |
Why?
| von Willebrand Factor | 1 | 1990 | 70 | 0.010 |
Why?
| DNA, Recombinant | 2 | 1979 | 46 | 0.000 |
Why?
| RNA Probes | 1 | 1988 | 13 | 0.000 |
Why?
| Autoradiography | 1 | 1988 | 73 | 0.000 |
Why?
| HLA-DR Antigens | 1 | 1990 | 223 | 0.000 |
Why?
| Histocytochemistry | 1 | 1988 | 82 | 0.000 |
Why?
| Metaphase | 1 | 1988 | 29 | 0.000 |
Why?
| Microbial Collagenase | 1 | 1987 | 12 | 0.000 |
Why?
| Cytoplasm | 1 | 1988 | 265 | 0.000 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 1988 | 50 | 0.000 |
Why?
| Light | 1 | 1990 | 359 | 0.000 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 1988 | 110 | 0.000 |
Why?
| Culture Techniques | 1 | 1987 | 81 | 0.000 |
Why?
| Cross Reactions | 1 | 1988 | 132 | 0.000 |
Why?
| Leukemia, Radiation-Induced | 1 | 1987 | 4 | 0.000 |
Why?
| Proto-Oncogene Proteins c-sis | 1 | 1987 | 35 | 0.000 |
Why?
| Leukemia, Experimental | 1 | 1987 | 27 | 0.000 |
Why?
| Cricetulus | 1 | 1987 | 108 | 0.000 |
Why?
| Diterpenes | 1 | 1986 | 32 | 0.000 |
Why?
| Inflammation | 1 | 1997 | 2737 | 0.000 |
Why?
| Genetic Markers | 1 | 1987 | 336 | 0.000 |
Why?
| Incidence | 1 | 1991 | 2636 | 0.000 |
Why?
| Lipopolysaccharides | 1 | 1988 | 877 | 0.000 |
Why?
| Aged, 80 and over | 1 | 1996 | 7055 | 0.000 |
Why?
| Poly A | 1 | 1982 | 48 | 0.000 |
Why?
| DNA-Directed RNA Polymerases | 1 | 1979 | 54 | 0.000 |
Why?
| Retrospective Studies | 1 | 1991 | 14455 | 0.000 |
Why?
|
|
Roop's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|